BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23527138)

  • 21. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
    Villacres MC; Zuo J; Bergmann CC
    Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
    Harmon JR; Spengler JR; Coleman-McCray JD; Nichol ST; Spiropoulou CF; McElroy AK
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.
    Dervillez X; Qureshi H; Chentoufi AA; Khan AA; Kritzer E; Yu DC; Diaz OR; Gottimukkala C; Kalantari M; Villacres MC; Scarfone VM; McKinney DM; Sidney J; Sette A; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2013 Nov; 191(10):5124-38. PubMed ID: 24101547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
    Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
    PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a Recombinant Nucleocapsid Protein of Rift Valley Fever Virus in Vero Cells as an Immunofluorescence Antigen and Its Use for Serosurveillance in Traditional Cattle Herds in Zambia.
    Saasa N; Kajihara M; Dautu G; Mori-Kajihara A; Fukushi S; Sinkala Y; Morikawa S; Mweene A; Takada A; Yoshimatsu K; Arikawa J
    Vector Borne Zoonotic Dis; 2018 May; 18(5):273-277. PubMed ID: 29652643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective CD8
    Ma Y; Tang K; Zhang Y; Zhang C; Cheng L; Zhang F; Zhuang R; Jin B; Zhang Y
    Virol J; 2020 Oct; 17(1):146. PubMed ID: 33028368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
    Veit S; Jany S; Fux R; Sutter G; Volz A
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein.
    Van Epps HL; Schmaljohn CS; Ennis FA
    J Virol; 1999 Jul; 73(7):5301-8. PubMed ID: 10364276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
    Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T
    Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
    Akondy RS; Monson ND; Miller JD; Edupuganti S; Teuwen D; Wu H; Quyyumi F; Garg S; Altman JD; Del Rio C; Keyserling HL; Ploss A; Rice CM; Orenstein WA; Mulligan MJ; Ahmed R
    J Immunol; 2009 Dec; 183(12):7919-30. PubMed ID: 19933869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge.
    Moreno S; Calvo-Pinilla E; Devignot S; Weber F; Ortego J; Brun A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008942. PubMed ID: 33275608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8
    Ma Y; Tang K; Zhang Y; Zhang C; Zhang Y; Jin B; Ma Y
    Virol J; 2020 Jan; 17(1):15. PubMed ID: 32005266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8⁺ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848.
    Zhao K; Wang H; Wu C
    Vaccine; 2011 Sep; 29(38):6670-8. PubMed ID: 21745520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
    Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
    Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.